Based on the observation of our in vivo results that sitagliptin administration decreased macrophage infiltration and increased plasma levels of active GLP-1, we predicted that sitagliptin would indirectly influence GLP-1 to regulate macrophage infiltration and macrophage-derived ROS production in AAAs. The gene discussed is GCG; the disease is achalasia-alacrima syndrome.